RamSoft is entering a new distributorship agreement with Koios Medical, which will see Koios' AI software integrated into RamSoft's cloud-native RIS/PACS platforms.
This agreement will give RamSoft customers access to Koios' AI software for women's health. Koios' offerings include Smart Ultrasound, an AI-powered clinical decision support product for breast and thyroid cancer detection and diagnosis.
With this agreement, RamSoft's women's health portfolio now includes the following:
- Stana, a breast tracking and reporting platform.
- iCAD's Profound AI 2D and AI-based cancer detection and density platform.
- Therapixel's MammoScreen 2D and 3D comprehensive breast cancer screening AI software.
- Ikonopedia, a web-based breast reporting and tracking platform, including BI-RADS-compliant structured reporting.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
